Across TCGA pan-cancer cohorts, AGBL5-IT1 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of AGBL5-IT1’s most consistent transcriptional readouts.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where AGBL5-IT1 RNA is repressed in tumor relative to normal tissue. In most cancer types AGBL5-IT1 is over-expressed in tumor, although a few such as BLCA and UCEC show the opposite, repressed pattern.
BLCA, UCEC, and BRCA are the cancer types where AGBL5-IT1 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in AGBL5-IT1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.